10:12 AM EDT, 08/07/2024 (MT Newswires) -- Ocular Therapeutix ( OCUL ) shares rose 4.3% in recent Wednesday trading after the biopharmaceutical company posted higher Q2 net revenue from a year earlier that also topped analysts' forecasts. The company reported a Q2 net loss of $0.26 per diluted share, unchanged from a year earlier. Analysts polled by Capital IQ expected...

10:09 AM EDT, 08/07/2024 (MT Newswires) -- Advantage Solutions ( ADV ) on Wednesday reported a Q2 net loss of $0.31 per diluted share compared with a $0.03 loss a year earlier. The lone analyst polled by Capital IQ expected a $0.24 loss. Revenue for the quarter ended June 30 was $873.4 million, compared with $963.8 million a year earlier....

Talis Biomedical Corp ( TLIS ) shares are trading lower by 49% to $4.58 during Wednesday’s session. The company announced board restructuring, appointed new directors and updated investors on potential bankruptcy proceedings. What Happened? The company says on July 31, Talis Biomedical Corporation’s board, guided by the Nominating and Corporate Governance Committee, began restructuring its composition. Heinrich Dreismann resigned effective...

10:12 AM EDT, 08/07/2024 (MT Newswires) -- Price: 76.81, Change: +0.27, Percent Change: +0.35 ...